Published in Aliment Pharmacol Ther on August 01, 2007
Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut (2012) 2.60
Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol (2010) 2.22
A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol (2009) 1.60
Genomic insights into bifidobacteria. Microbiol Mol Biol Rev (2010) 1.57
Irritable bowel syndrome, gut microbiota and probiotics. J Neurogastroenterol Motil (2011) 1.23
Probiotic Therapy of the Irritable Bowel Syndrome: Why Is the Evidence Still Poor and What Can Be Done About It? J Neurogastroenterol Motil (2015) 1.23
Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice -- an evidence-based international guide. Aliment Pharmacol Ther (2013) 1.21
Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol (2013) 1.20
Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis. World J Gastroenterol (2014) 1.19
Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles. Gastroenterology (2008) 1.14
Effect of a fermented milk containing Bifidobacterium lactis DN-173010 on Chinese constipated women. World J Gastroenterol (2008) 1.05
Gut microbiota as potential orchestrators of irritable bowel syndrome. Gut Liver (2015) 1.03
A candidate probiotic with unfavourable effects in subjects with irritable bowel syndrome: a randomised controlled trial. BMC Gastroenterol (2010) 1.01
Probiotic effects on intestinal fermentation patterns in patients with irritable bowel syndrome. World J Gastroenterol (2008) 0.99
Comparative genomic analysis of 45 type strains of the genus Bifidobacterium: a snapshot of its genetic diversity and evolution. PLoS One (2015) 0.97
Probiotic treatment of irritable bowel syndrome in children. Ger Med Sci (2010) 0.97
The gastrointestinal microbiome: a malleable, third genome of mammals. Mamm Genome (2009) 0.95
Are there any different effects of Bifidobacterium, Lactobacillus and Streptococcus on intestinal sensation, barrier function and intestinal immunity in PI-IBS mouse model? PLoS One (2014) 0.93
Recommendations for probiotic use in humans-a 2014 update. Pharmaceuticals (Basel) (2014) 0.92
Probiotic therapy for irritable bowel syndrome. Gastroenterol Hepatol (N Y) (2010) 0.92
Helping patients make informed choices about probiotics: a need for research. Am J Gastroenterol (2009) 0.88
A randomised controlled trial of a probiotic 'functional food' in the management of irritable bowel syndrome. BMC Gastroenterol (2013) 0.87
Pediatric functional constipation treatment with Bifidobacterium-containing yogurt: a crossover, double-blind, controlled trial. World J Gastroenterol (2011) 0.86
Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World J Gastroenterol (2016) 0.85
Gut inflammation in chronic fatigue syndrome. Nutr Metab (Lond) (2010) 0.85
Visceral analgesics: drugs with a great potential in functional disorders? Curr Opin Pharmacol (2008) 0.85
Effect of the consumption of a fermented dairy product containing Bifidobacterium lactis DN-173 010 on constipation in childhood: a multicentre randomised controlled trial (NTRTC: 1571). BMC Pediatr (2009) 0.85
Bifidobacteria and Their Role as Members of the Human Gut Microbiota. Front Microbiol (2016) 0.84
Effect of composite yogurt enriched with acacia fiber and Bifidobacterium lactis. World J Gastroenterol (2012) 0.84
Acquired tolerance to oxidative stress in Bifidobacterium longum 105-A via expression of a catalase gene. Appl Environ Microbiol (2012) 0.83
Actual concept of "probiotics": is it more functional to science or business? World J Gastroenterol (2013) 0.82
Novel therapeutic approaches in IBS. Curr Opin Pharmacol (2007) 0.82
The human microbiome and probiotics: implications for pediatrics. Curr Probl Pediatr Adolesc Health Care (2008) 0.82
Probiotics, prebiotics and the gastrointestinal tract in health and disease. Inflammopharmacology (2014) 0.81
The efficacy of a synbiotic containing Bacillus Coagulans in treatment of irritable bowel syndrome: a randomized placebo-controlled trial. Gastroenterol Hepatol Bed Bench (2014) 0.80
Detection and Identification of Probiotic Lactobacillus plantarum Strains by Multiplex PCR Using RAPD-Derived Primers. Int J Mol Sci (2015) 0.79
Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice. Gut Microbes (2015) 0.79
Do probiotics improve symptoms in patients with irritable bowel syndrome? Therap Adv Gastroenterol (2009) 0.78
Probiotic Fermented Milk Containing Dietary Fiber Has Additive Effects in IBS with Constipation Compared to Plain Probiotic Fermented Milk. Gut Liver (2011) 0.78
Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate. World J Gastroenterol (2016) 0.78
Is irritable bowel syndrome an infectious disease? World J Gastroenterol (2016) 0.78
Gut microbiota and sirtuins in obesity-related inflammation and bowel dysfunction. J Transl Med (2011) 0.77
Lactobacillus acidophilus stimulates intestinal P-glycoprotein expression via a c-Fos/c-Jun-dependent mechanism in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol (2016) 0.76
Systematic review and meta-analysis: the effects of fermented milk with Bifidobacterium lactis CNCM I-2494 and lactic acid bacteria on gastrointestinal discomfort in the general adult population. Therap Adv Gastroenterol (2016) 0.75
Gut microbiota, probiotics, and human health. Biosci Microbiota Food Health (2013) 0.75
Spatial Localization and Binding of the Probiotic Lactobacillus farciminis to the Rat Intestinal Mucosa: Influence of Chronic Stress. PLoS One (2015) 0.75
Probiotics and irritable bowel syndrome. Microb Ecol Health Dis (2012) 0.75
The Effect of Probiotic Yogurt on Constipation in Pregnant Women: A Randomized Controlled Clinical Trial. Iran Red Crescent Med J (2016) 0.75
Therapeutic Modulation of Gut Microbiota in Functional Bowel Disorders. J Neurogastroenterol Motil (2017) 0.75
Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS. PLoS One (2017) 0.75
Microbiome and metabolome data integration provides insight into health and disease. Transl Res (2017) 0.75
Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet (2000) 3.47
Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Lancet (1996) 3.15
HIV infection en route to endogenization: two cases. Clin Microbiol Infect (2014) 2.63
Identification and biological activity of the active metabolite of clopidogrel. Thromb Haemost (2000) 2.45
Review article: bifidobacteria as probiotic agents -- physiological effects and clinical benefits. Aliment Pharmacol Ther (2005) 2.35
Impaired fasting pyloric compliance in gastroparesis and the therapeutic response to pyloric dilatation. Aliment Pharmacol Ther (2014) 2.19
Impact of pain in health related quality of life of patients with systemic sclerosis. Rheumatology (Oxford) (2006) 2.15
Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome. Gastroenterology (1999) 2.01
Acute perforation of colonic diverticula associated with short-term indomethacin. Lancet (1978) 1.94
[Erysipelas: epidemiological, clinical and therapeutic data (111 cases)]. Ann Dermatol Venereol (1991) 1.66
Effect of prostaglandin E 1 on glucose, water, and electrolyte absorption in the human jejunum. Gastroenterology (1973) 1.62
The clinicopathological features of extensive small intestinal CD4 T cell infiltration. Gut (1999) 1.54
Validation of a self-questionnaire for assessing the control of allergic rhinitis. Clin Exp Allergy (2011) 1.53
Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid. Arch Dermatol (1993) 1.52
Long-term results of faecal diversion for refractory perianal Crohn's disease. Colorectal Dis (2001) 1.46
Oesophageal mucosal involvement in patients with systemic sclerosis receiving proton pump inhibitor therapy. Aliment Pharmacol Ther (2006) 1.46
Effects of polyethylene glycol 4000 on 24-h manometric recordings of left colonic motor activity. Eur J Gastroenterol Hepatol (2001) 1.46
Prolonged stationary colonic motility recording in seven patients with severe constipation secondary to antidepressants. Neurogastroenterol Motil (2000) 1.45
Postoperative management of stage II/III colon cancer: a decision analysis. Gastroenterology (1999) 1.45
Cholesterol and bile acid biodynamics after total small bowel resection and bile diversion in humans. Gastroenterology (1993) 1.38
Botulinum A toxin as a treatment for overactive rectum with associated faecal incontinence. Colorectal Dis (2012) 1.38
Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease. Gastroenterology (2000) 1.33
A randomised clinical trial of the effect of informed consent on the analgesic activity of placebo and naproxen in cancer pain. Clin Trials Metaanal (1994) 1.32
Alpha-chain disease. Pathogenesis and relation to Mediterranean lymphoma. Lancet (1973) 1.31
Impaired interferon gamma-mediated immunity and susceptibility to mycobacterial infection in childhood. Pediatr Res (2001) 1.31
The immunosuppressant SR 31747 blocks cell proliferation by inhibiting a steroid isomerase in Saccharomyces cerevisiae. Mol Cell Biol (1996) 1.30
Human interferon-gamma-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion. Immunol Rev (2000) 1.28
Segmental reversal of the small bowel as an alternative to intestinal transplantation in patients with short bowel syndrome. Ann Surg (1997) 1.28
Palliative treatment of rectosigmoid carcinoma by laser endoscopic photoablation. Gastroenterology (1987) 1.27
Pathological study of alpha-chain disease, with special emphasis on evolution. Cancer (1977) 1.23
Distinction between coeliac disease and refractory sprue: a simple immunohistochemical method. Histopathology (2000) 1.22
A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor. J Clin Invest (1998) 1.22
Correlation between echographic gastric emptying and appetite: influence of psyllium. Gut (1992) 1.20
Inherited disorders of IL-12- and IFNgamma-mediated immunity: a molecular genetics update. Mol Immunol (2002) 1.19
Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther (2000) 1.15
Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure. J Med Genet (2004) 1.10
Metronidazole for antibiotic-associated pseudomembraneous colitis. Lancet (1978) 1.09
Geometrical calibration of X-ray imaging chains for three-dimensional reconstruction. Comput Med Imaging Graph (1994) 1.08
[Clinical, anatomo-pathological and immunochemical study of a further case of alpha chain disease followed for 5 years]. Rev Eur Etud Clin Biol (1972) 1.08
Exhaled volatile organic compounds identify patients with colorectal cancer (Br J Surg 2013; 100: 144-150). Br J Surg (2013) 1.06
The tyrosine kinase Hck is an inhibitor of HIV-1 replication counteracted by the viral vif protein. J Biol Chem (2001) 1.06
Kinetics of the persistence of chromosomal DNA from genetically engineered Escherichia coli introduced into soil. Appl Environ Microbiol (1993) 1.06
Long-term results of ileal pouch-anal anastomosis for colorectal Crohn's disease. Dis Colon Rectum (2001) 1.05
Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization. Blood (1998) 1.04
[A further case of alpha chain disease in a Eurasian]. Ann Med Interne (Paris) (1970) 1.01
Cavitation of mesenteric lymph nodes, splenic atrophy, and a flat small intestinal mucosa. Report of six cases. Gastroenterology (1984) 1.00
Pancreatic cholera. Sudies on tumoral secretions and pathophysiology of diarrhea. Gastroenterology (1975) 1.00
Subacute posttraumatic ascending myelopathy after spinal cord injury. Report of three cases. J Neurosurg (2000) 0.99
Letter: Vitamin B12 malabsorption in chronic pancreatitis. Gastroenterology (1974) 0.97
Biofeedback training for constipation in adults and children. Dis Colon Rectum (1987) 0.97
Diffuse alveolar haemorrhage: factors associated with in-hospital and long-term mortality. Eur Respir J (2009) 0.96
Effects of cholecystokinin and metoclopramide on jejunal movements of water and electrolytes and on transit time of luminal fluid in man. Eur J Clin Invest (1972) 0.96
International validation of a health-related quality of life questionnaire in patients with erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2008) 0.96
Clinical criteria for the diagnosis of bullous pemphigoid: a reevaluation according to immunoblot analysis of patient sera. Dermatology (2004) 0.95
Effects of nematode infection on sensitivity to intestinal distension: role of tachykinin NK2 receptors. Eur J Pharmacol (1997) 0.95
Association of cimetidine and bone-marrow suppression in man. Dig Dis Sci (1979) 0.95
Effects of intravenous and intraduodenal fat on jejunal motility and on plasma cholecystokinin in man. Dig Dis Sci (1988) 0.95
Relationship between rectal sensitivity, symptoms intensity and quality of life in patients with irritable bowel syndrome. Aliment Pharmacol Ther (2008) 0.94
Cryptosporidium parvum infection stimulates the secretion of TGF-beta, IL-8 and RANTES by Caco-2 cell line. Parasitol Res (2000) 0.93
Antiproliferative effects of SR31747A in animal cell lines are mediated by inhibition of cholesterol biosynthesis at the sterol isomerase step. Eur J Biochem (1998) 0.93
Description of an adenovirus A31 outbreak in a paediatric haematology unit. Bone Marrow Transplant (2006) 0.93
[Immunocytes and immunoglobulins of the digestive tract during primary immune deficiencies in adults. Study of 26 cases]. Gastroenterol Clin Biol (1977) 0.92
Effects of pregnancy and chorionic growth hormone upon insulin secretion. Endocrinology (1969) 0.92
[Regional enteritis in monozygotic twins. Report of an 11th case and review of the literature (author's transl)]. Gastroenterol Clin Biol (1977) 0.92
Bronchoalveolar lavage eosinophilia associated with Pneumocystis carinii pneumonitis in AIDS patients. Comparative study with non-AIDS patients. Chest (1989) 0.92
Very late onset small intestinal B cell lymphoma associated with primary intestinal lymphangiectasia and diffuse cutaneous warts. Gut (2000) 0.91
Effect of ranitidine on resting pressure and pentagastrin response of human lower esophageal sphincter. Dig Dis Sci (1981) 0.91
[Controlled study of propranolol in the prevention of recurrent hemorrhage in cirrhotic patients]. Gastroenterol Clin Biol (1987) 0.91
Laparoscopic ileocecal resection in Crohn's disease: a case-matched comparison with open resection. Surg Endosc (2003) 0.90
Sensory cortical tongue representation in man. J Neurosurg (1983) 0.90
Watermelon stomach in systemic sclerosis: its incidence and management. Aliment Pharmacol Ther (2008) 0.90
[Celiac disease in adults. (48 cases) I. Anatomo-clinical, biological and radiological study; its course under a non-gluten diet]. Arch Fr Mal App Dig (1975) 0.90
Malignant lymphoma of the small bowel associated with diffuse nodular lymphoid hyperplasia. N Engl J Med (1985) 0.90
[Transit time and calibre of the small intestine in man: measurement by a dye dilution curve during intestinal perfusion of isotonic solutions of NaCl and KCl]. Biol Gastroenterol (Paris) (1969) 0.89
Clinical assessment of a new stereoscopic digital angiography system. Cardiovasc Intervent Radiol (1998) 0.89
High levels of interferon gamma in the plasma of children with complete interferon gamma receptor deficiency. Pediatrics (2001) 0.89
Intravenous immunoglobulins as treatment of life threatening esophageal involvement in polymyositis and dermatomyositis. J Rheumatol (1999) 0.88
Colonic transit time of radiopaque markers and rectoanal manometry in patients complaining of constipation. Dis Colon Rectum (1986) 0.88
Role of kinin B1 and B2 receptors and mast cells in post intestinal infection-induced hypersensitivity to distension. Neurogastroenterol Motil (1998) 0.88
HIV-2 and SIV nef proteins target different Src family SH3 domains than does HIV-1 Nef because of a triple amino acid substitution. J Biol Chem (2000) 0.88
Cyclic (nocturnal) total parenteral nutrition in hospitalized adult patients with severe digestive diseases. Report of a prospective study. Gastroenterology (1981) 0.88
Testing of anti-HIV antibodies in saliva. AIDS (1994) 0.88
Gastric electrical stimulation modulates hypothalamic corticotropin-releasing factor-producing neurons during post-operative ileus in rat. Neuroscience (2007) 0.87
[Budd-Chiari syndrome associated with renal carcinoma. A clinico-pathological study of two cases (author's transl)]. Arch Fr Mal App Dig (1975) 0.87
Recurrent Mycobacterium avium osteomyelitis associated with a novel dominant interferon gamma receptor mutation. Pediatrics (2001) 0.87
Rapid enzymatic degradation of [125I] (Tyr 10) FGF (1-10) by serum in vitro and involvement in the determination of circulating FGF by RIA. Biochem Biophys Res Commun (1987) 0.87
[Familial occurrence of cancer of the colon and the rectum: results of a 3-year case-control survey]. Gastroenterol Clin Biol (1984) 0.87
Founder effect for a 26-bp deletion in the RFXANK gene in North African major histocompatibility complex class II-deficient patients belonging to complementation group B. Immunogenetics (2000) 0.86
Treatment and long-term outcome of chronic radiation esophagitis after radiation therapy for head and neck tumors. A report of 13 cases. Dig Dis Sci (1993) 0.86
Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients. Arthritis Care Res (Hoboken) (2010) 0.86
Scalp-ear-nipple (Finlay-Marks) syndrome: a familial case with renal involvement. Clin Genet (1999) 0.86
Improvement of gene expression analysis by RQ-PCR technology: addition of BSA. Leukemia (2004) 0.85
Effects of two oral erythromycin ethylsuccinate formulations on the motility of the small intestine in human beings. Antimicrob Agents Chemother (1996) 0.85
Parenteral nutrition in inflammatory bowel disease. Gut (1986) 0.85
Clinical trial: Radiofrequency energy delivery in proton pump inhibitor-dependent gastro-oesophageal reflux disease patients. Aliment Pharmacol Ther (2008) 0.85
Effects of prostaglandin E1 on net and unidirectional movements of water and electrolytes across the jejunal mucosa in man. Gut (1971) 0.85
In vivo evaluation of a new system for 3D computerized angiography. Phys Med Biol (1994) 0.85
Intratemporal vascular malformations (angiomas): particular clinical features. J Otolaryngol (1994) 0.85
Cholesterol-lowering effect of continuous enteral nutrition in man. Clin Nutr (1991) 0.84